JPRN-UMIN000010450
Completed
未知
Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized double-blind comparative study of esomeprazole 20mg vs. rabeprazole 10mg - Speedy study
Juntendo University School of Medicine, Department of Gastroenterology and Hepatology0 sites200 target enrollmentApril 10, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Juntendo University School of Medicine, Department of Gastroenterology and Hepatology
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Patients with a history of gastrointestinal resection or vagotomy (2\) Patients with warning signs such as vomiting, gastrointestinal bleeding (including findings of hematemesis, melena, and anemia), and sudden weight loss (3\) Patients with peptic ulcer (except those in scarring stage) (4\) Patients with a history of, or who currently have, any of the following diseases: \- Zollinger\-Ellison syndrome \- Inflammatory Bowel Disease (IBD) \- Irritable Bowel Syndrome (IBS) \- Esophageal stricture \- Esophageal achalasia \- Malabsorption \- Cerebrovascular disorders such as cerebral hemorrhage and cerebral infarction (5\) Patients whose participation in this study would be contraindicated due to complications such as serious hepatic disease, renal disease, or cardiac disease. (6\) Patients with a confirmed, or suspected, malignant lesion (7\) Women who are pregnant or who may possibly be pregnant, and lactating mothers (8\) Patients under atazanavir sulfate administration (9\) Patients receiving treatment with proton pump inhibitors, H2\-receptor antagonists, prokinetic agents, gastric mucosa protective agents, anticholinergics, antidepressants, antianxiety agents, steroids (excluding external preparations), non\-steroid anti\-inflammatory drugs (NSAIDs), aspirin preparations including low\-dose aspirin,anticoagulant drugs and bisphosphonate drugs in the past 2 week prior to treatment. (10\) Other patients whom the investigator considers unsuitable for admission to the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of omeprazole 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an indexpatients with reflux esophagitisJPRN-UMIN000003078Japan Dyspepsia Society220
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors for gastric ulcers after endoscopic submucosal dissection (ESD): a randomized comparative study of omeprazole iv vs. esomeprazole pogastric cancerJPRN-UMIN000010958Department of Gastroenterology, Ishikawa Prefectural Central Hospital200
Completed
Not Applicable
Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of omeprazole 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an indexreflux esophagitisJPRN-UMIN000002955Japan Dyspepsia Society220
Recruiting
Not Applicable
Investigation of the usefulness of Rikkunshi-to in functional dyspepsiFunctional DyspepsiaJPRN-jRCT1061220076Yachida Tatsuo90
Recruiting
Phase 3
Comparison of the effect of baclofen and proton pump inhibitors in patients with gastroesophageal reflux diseasegastroesophageal reflux disease.Gastro-esophageal reflux diseaseIRCT20210308050634N1Islamic Azad University60